[PBBANK] QoQ Quarter Result on 30-Jun-2016 [#2]

Stock
[PBBANK] PUBLIC BANK BHD
Announcement Date
28-Jul-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- 2.14%
YoY- 4.96%
Quarter Report
Latest QR
Upcoming QR
PBBANK's Result
PBBANK's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 5,028,185 5,084,083 5,031,100 4,980,256 5,007,301 4,929,046 4,914,523 1.53%
PBT 1,631,472 1,792,711 1,558,242 1,551,521 1,651,558 1,857,776 1,613,794 0.72%
Tax -366,129 -293,442 -305,728 -280,929 -406,498 -350,605 -396,829 -5.22%
NP 1,265,343 1,499,269 1,252,514 1,270,592 1,245,060 1,507,171 1,216,965 2.63%
-
NP to SH 1,247,981 1,482,782 1,238,150 1,256,153 1,229,790 1,492,428 1,201,395 2.56%
-
Tax Rate 22.44% 16.37% 19.62% 18.11% 24.61% 18.87% 24.59% -
Total Cost 3,762,842 3,584,814 3,778,586 3,709,664 3,762,241 3,421,875 3,697,558 1.17%
-
Net Worth 34,196,617 34,213,222 32,826,175 32,443,500 31,111,671 31,230,991 29,640,055 9.99%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div - 1,235,678 - 1,003,988 - 1,235,678 - -
Div Payout % - 83.34% - 79.93% - 82.80% - -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 34,196,617 34,213,222 32,826,175 32,443,500 31,111,671 31,230,991 29,640,055 9.99%
NOSH 3,882,138 3,882,138 3,882,138 3,882,138 3,882,138 3,882,138 3,882,138 0.00%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 25.17% 29.49% 24.90% 25.51% 24.86% 30.58% 24.76% -
ROE 3.65% 4.33% 3.77% 3.87% 3.95% 4.78% 4.05% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 130.21 131.66 130.29 128.97 129.67 127.65 127.27 1.53%
EPS 32.32 38.40 32.06 32.53 31.85 38.65 31.11 2.57%
DPS 0.00 32.00 0.00 26.00 0.00 32.00 0.00 -
NAPS 8.8558 8.8601 8.5009 8.4018 8.0569 8.0878 7.6758 9.99%
Adjusted Per Share Value based on latest NOSH - 3,882,138
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 25.90 26.18 25.91 25.65 25.79 25.39 25.31 1.54%
EPS 6.43 7.64 6.38 6.47 6.33 7.69 6.19 2.56%
DPS 0.00 6.36 0.00 5.17 0.00 6.36 0.00 -
NAPS 1.7612 1.7621 1.6906 1.6709 1.6023 1.6085 1.5265 9.99%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 19.90 19.72 19.82 19.40 18.78 18.52 17.52 -
P/RPS 15.28 14.98 15.21 15.04 14.48 14.51 13.77 7.17%
P/EPS 61.57 51.36 61.81 59.64 58.97 47.92 56.31 6.12%
EY 1.62 1.95 1.62 1.68 1.70 2.09 1.78 -6.08%
DY 0.00 1.62 0.00 1.34 0.00 1.73 0.00 -
P/NAPS 2.25 2.23 2.33 2.31 2.33 2.29 2.28 -0.87%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 20/04/17 02/02/17 20/10/16 28/07/16 20/04/16 03/02/16 22/10/15 -
Price 19.92 20.14 19.80 19.56 19.02 18.38 18.64 -
P/RPS 15.30 15.30 15.20 15.17 14.67 14.40 14.65 2.93%
P/EPS 61.64 52.45 61.75 60.13 59.72 47.56 59.91 1.91%
EY 1.62 1.91 1.62 1.66 1.67 2.10 1.67 -2.00%
DY 0.00 1.59 0.00 1.33 0.00 1.74 0.00 -
P/NAPS 2.25 2.27 2.33 2.33 2.36 2.27 2.43 -4.99%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment